9.48
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt TPST?
Forum
Prognose
Aktiensplit
Tempest Therapeutics Inc Aktie (TPST) Neueste Nachrichten
Tempest Therapeutics Inc. Building a Base Near SupportAnalyst Upgrade & Entry and Exit Point Strategies - newsyoung.net
What data driven models say about Tempest Therapeutics Inc.’s futureMarket Sentiment Summary & Reliable Entry Point Alerts - Newser
Custom watchlist performance reports with Tempest Therapeutics Inc.2025 Buyback Activity & Safe Capital Growth Stock Tips - Newser
Can machine learning forecast Tempest Therapeutics Inc. recoveryJuly 2025 Sentiment & Smart Money Movement Alerts - Newser
Technical analysis overview for Tempest Therapeutics Inc. stockJuly 2025 Short Interest & Low Risk Growth Stock Ideas - Newser
Real time alert setup for Tempest Therapeutics Inc. performance2025 Sector Review & Low Risk High Reward Ideas - Newser
Why Tempest Therapeutics Inc. stock attracts strong analyst attentionMarket Volume Report & Weekly Chart Analysis and Trade Guides - Newser
Is Tempest Therapeutics Inc. stock a growth or value playRate Cut & Reliable Breakout Forecasts - Newser
Is Tempest Therapeutics Inc. stock bottoming out2025 Market Outlook & Fast Momentum Stock Entry Tips - Newser
Pattern recognition hints at Tempest Therapeutics Inc. upsidePortfolio Return Report & Weekly High Momentum Picks - Newser
Quantitative breakdown of Tempest Therapeutics Inc. recent moveEarnings Recap Report & Expert Approved Momentum Trade Ideas - Newser
Analyzing drawdowns of Tempest Therapeutics Inc. with statistical toolsChart Signal and Short-Term Forecast Tracker - Newser
Predicting Tempest Therapeutics Inc. trend using moving averagesFree Entry Alert With Low Drawdown Strategy - Newser
Is Tempest Therapeutics Inc. a play on infrastructure spendingBottom Formation Alert - thegnnews.com
How Interest Rate Changes Impact Tempest Therapeutics Inc. Stock PerformanceBuy Opportunity Forecast for Fast Traders - Newser
Tempest Therapeutics Reports Q2 2025 Financial Results - TipRanks
Tempest Therapeutics Inc. stock chart pattern explainedShort Squeeze Opportunities with Indicators - Newser
What makes Tempest Therapeutics Inc. stock price move sharplyYield Curve Outlook and Long-Term Implication Summary - Newser
Tempest Therapeutics TPST 2025Q2 Earnings Preview Downside Risk Amid Uncertain Revenue Expectations - AInvest
Tempest Therapeutics Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Tempest Therapeutics reports Q2 EPS ($2.07), consensus ($2.65) - TipRanks
Tempest Therapeutics: A Case Study in Operational Turnaround and Biotech Resilience - AInvest
Tempest Reports Second Quarter 2025 Financial Results and Provides Business Update - GlobeNewswire
Tempest Secures Triple Regulatory Wins for Cancer Drug Amezalpat as Q2 Losses Narrow - Stock Titan
Is it too late to sell Tempest Therapeutics Inc.Pattern Recognition Tool for ROI Investors - Newser
Tempest Therapeutics Inc. stock outlook for YEARFree Smart Trade Plans With Risk Protection - Newser
What technical models suggest about Tempest Therapeutics Inc.’s comeback - Newser
Multi factor analysis applied to Tempest Therapeutics Inc.Short Term Gain Strategy with AI Logic - Newser
Tempest Therapeutics Inc. Company’s Quarterly Earnings Growth: What the Numbers SayROI Focused Setup Screener With Exit Markers - Newser
Published on: 2025-08-09 23:28:19 - Newser
How Tempest Therapeutics Inc. stock performs during market volatilityFree Chart Breakout Buy Signal Detection - Newser
Tempest Therapeutics Inc expected to post a loss of $2.60 a shareEarnings Preview - TradingView
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):